Package 63323-093-30

Brand: sodium chloride

Generic: sodium chloride
NDC Package

Package Facts

Identity

Package NDC 63323-093-30
Digits Only 6332309330
Product NDC 63323-093
Product ID 63323-093_570d0b0e-2f05-4b8b-af0f-ad8e7588aad9
Description

25 VIAL, PLASTIC in 1 TRAY (63323-093-30) / 30 mL in 1 VIAL, PLASTIC (63323-093-01)

Marketing

Marketing Status
Marketed Since 2021-04-28
Brand sodium chloride
Generic sodium chloride
Sample Package No

Linked Drug Pages (1)

Sodium Chloride ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "570d0b0e-2f05-4b8b-af0f-ad8e7588aad9", "openfda": {"unii": ["451W47IQ8X"], "rxcui": ["1807571"], "spl_set_id": ["4a655cde-283f-4ec8-a3d9-5f539c55c204"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "25 VIAL, PLASTIC in 1 TRAY (63323-093-30)  / 30 mL in 1 VIAL, PLASTIC (63323-093-01)", "package_ndc": "63323-093-30", "marketing_start_date": "20210428"}], "brand_name": "Sodium Chloride", "product_id": "63323-093_570d0b0e-2f05-4b8b-af0f-ad8e7588aad9", "dosage_form": "INJECTION, SOLUTION, CONCENTRATE", "pharm_class": ["Increased Large Intestinal Motility [PE]", "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]", "Osmotic Activity [MoA]", "Osmotic Laxative [EPC]"], "product_ndc": "63323-093", "generic_name": "Sodium Chloride", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Sodium Chloride", "active_ingredients": [{"name": "SODIUM CHLORIDE", "strength": "4 meq/mL"}], "application_number": "ANDA212248", "marketing_category": "ANDA", "marketing_start_date": "20210428", "listing_expiration_date": "20261231"}